-relin
A hormone-releasing peptide, often a GnRH analogue used in prostate and breast cancer.
- Drugs ending in -relin: 25
- Approved somewhere: 8
- With a US drug page: 7
- Stem
- -relin
- Class
- Peptides that make the pituitary release its hormones
Approved and clinical-stage drugs in ChEMBL whose names ending in -relin or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Corticorelin ovine triflutate | Approved | — | Diagnostic agent |
| Histrelin | Approved | GNRHR | Gonadotropin-releasing hormone receptor agonist |
| Nafarelin | Approved | GNRHR | Gonadotropin-releasing hormone receptor agonist |
| Buserelin | Approved | GNRHR | Gonadotropin-releasing hormone receptor agonist |
| Goserelin | Approved | GNRHR | Gonadotropin-releasing hormone receptor agonist |
| Triptorelin | Approved | GNRHR | Gonadotropin-releasing hormone receptor agonist |
| Ghrelin | Phase 3 | — | — |
| Gonadorelin | Phase 3 | GNRHR | Gonadotropin-releasing hormone receptor agonist |
| Triptorelin acetate | Phase 3 | UBA6 | Gonadotropin-releasing hormone receptor agonist |
| Zoptarelin doxorubicin | Phase 3 | GNRHR | Gonadotropin-releasing hormone receptor agonist |
| Deslorelin | Phase 2 | GNRHR | Gonadotropin-releasing hormone receptor agonist |
| Onvitrelin ucalontide | Phase 2 | Cell membrane, GNRHR | Cell membrane disrupting agent |
| Corticorelin acetate | Phase 1 | — | — |
| Macimorelin | Approved | GHSR | Ghrelin receptor agonist |
| Tesamorelin | Approved | GHRHR | Growth hormone-releasing hormone receptor agonist |
| Sermorelin acetate | — | GHRHR | Growth hormone-releasing hormone receptor agonist |
| Ulimorelin | Phase 3 | GHSR | Ghrelin receptor agonist |
| Anamorelin | Phase 2 | GHSR | Ghrelin receptor agonist |
| Capromorelin | Phase 2 | GHSR | Ghrelin receptor agonist |
| Ipamorelin | Phase 2 | — | — |
| Relamorelin | — | GHSR | Ghrelin receptor agonist |
| Tabimorelin | — | GHSR, CYP3A4 | Ghrelin receptor agonist |
| Protirelin | Phase 3 | TRHR | Thyrotropin-releasing hormone receptor agonist |
| Rovatirelin | Phase 3 | TRHR | Thyrotropin-releasing hormone receptor agonist |
| Taltirelin | — | TRHR | Thyrotropin-releasing hormone receptor agonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO